Orchid Pharma Limited (ORCHPHARMA) — share transfer

· NSE Neutral
📢 Key Event
Confirmation of compliance with SEBI Depositories and Participants Regulations 2018 for Q1 FY2026-27
💡 Investor Takeaway
The filing confirms routine regulatory compliance with no material changes or future guidance provided.

Orchid Pharma confirmed compliance with SEBI Depositories and Participants Regulations 2018 for Q1 FY2026-27 ending June 30, 2026, via its share transfer agent Abhipra Capital, reporting no pending transfers and no material issues.

📄 View Original Announcement (PDF)

About Orchid Pharma Limited (ORCHPHARMA)

Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE

Market Cap: ₹3,614.24 Cr P/E: 32.3

View full ORCHPHARMA stock details →

📡 Get AI alerts when ORCHPHARMA files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track ORCHPHARMA — Free

📊 More ORCHPHARMA filings

See all ORCHPHARMA filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

📡 Get AI alerts when ORCHPHARMA files new disclosures

Track ORCHPHARMA filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track ORCHPHARMA — Free

Free account · 2 AI queries/day